临床营养市场规模、份额、成长分析、按管理途径、按应用、按分销管道、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球临床营养市场规模估值为356亿美元，从2023年的387亿美元增长到2031年的711亿美元，预测期内（2024-2031年）复合年增长率为7.9%，预计将增长。

随着糖尿病和发炎性肠道疾病疾病等文明病相关疾病的日益流行，凸显了对客製化营养支持的需求，临床营养市场预计将显着成长。临床营养着重于利用必需的维生素、矿物质和营养素来优化代谢系统，以改善患者的健康。其应用涵盖心臟復健、肾臟透析、儿科营养、癌症支持、创伤復健和健康倡议等多个领域，凸显了其在医疗保健领域的多功能性。人口老化和政府对医疗保健研发的投资将进一步支持市场扩张。此外，亚太和拉丁美洲等新兴地区对临床营养的需求不断增长，以及家庭医疗保健解决方案的成长趋势，使全球临床营养市场在预测期内成为一个有吸引力的投资机会。随着医疗保健的不断发展，将临床营养纳入治疗计划和预防保健策略将在改善健康结果和满足不同人群的营养需求方面发挥重要作用。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 监管环境
• 专利分析
• 价值链分析
• PESTEL分析
• 市场吸引力指数
• 原料分析
• 价格分析

临床营养市场规模：依给药途径

• 市场概况
• 口服
• 胃肠外的
• 肠内的

临床营养市场规模：依应用分类

• 市场概况
• 癌症
• 神经系统疾病
• 胃肠道疾病
• 代谢紊乱
• 其他的

临床营养市场规模：依分销管道分类

• 市场概况
• 在线的
• 离线
  • 零售店
  • 企业销售管道
  • 其他的

临床营养市场规模：依最终用户分类

• 市场概况
• 儿科的
• 成人
• 老年人

临床营养市场规模：依营养成分分类

• 市场概况
• 以蛋白质为基础的营养
• 富含维生素和矿物质的营养
• 以碳水化合物为基础的营养
• 以脂肪为基础的营养

临床营养市场规模：按地区

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Abbott Laboratories（US）
• Nestle Health Science（Switzerland）
• Danone Nutricia（France）
• Fresenius Kabi（Germany）
• Baxter International（US）
• B. Braun Melsungen AG（Germany）
• Mead Johnson Nutrition（Reckitt）（US）
• GlaxoSmithKline（GSK）（UK）
• Pfizer（US）
• Ajinomoto Co., Inc.（Japan）
• Koninklijke DSM NV（Netherlands）
• Lonza Group（Switzerland）
• Cambrooke Therapeutics（US）
• Sichuan Kelun Pharmaceutical Co. Ltd.（China）
• Otsuka Pharmaceutical（Japan）
• Hormel Health Labs（US）
• Perrigo Company（Ireland）
• Hero Group（Switzerland）
• Victus（US）
• Entrocare Nutritional Solutions（UK）

结论和建议

Global Clinical Nutrition Market size was valued at USD 35.6 billion in 2022 and is poised to grow from USD 38.7 billion in 2023 to USD 71.1 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The clinical nutrition market is poised for significant growth, driven by the increasing prevalence of lifestyle-related diseases such as diabetes and inflammatory bowel disease, which highlight the need for tailored nutritional support. Clinical nutrition focuses on optimizing the metabolic system through essential vitamins, minerals, and nutrients aimed at enhancing patient health. Its applications span various sectors, including cardiac rehabilitation, renal dialysis, pediatric nutrition, cancer support, trauma recovery, and wellness initiatives, underpinning its versatility in healthcare. The aging population and substantial government investments in healthcare research and development further bolster market expansion. Additionally, the rising demand for clinical nutrition in emerging regions such as Asia-Pacific and Latin America, coupled with a growing trend towards home healthcare solutions, positions the global clinical nutrition market as an attractive investment opportunity during the forecast period. As healthcare continues to evolve, the integration of clinical nutrition into treatment plans and preventive care strategies will play a crucial role in improving health outcomes and addressing the nutritional needs of diverse populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Nutrition Market Segmental Analysis

Global Clinical Nutrition Market is segmented by Route of Administration, application, Distribution Channel, end user, Nutritional Content and region. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Enteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorder, Metabolic Disorder, and Others. Based on Distribution Channel, the market is segmented into Online and Offline. Based on end user, the market is segmented into Paediatric, Adults, and Geriatric. Based on By Nutritional Content, the market is segmented into Protein-Based Nutrition, Vitamin and Mineral-Rich Nutrition, Carbohydrate-Based Nutrition, and Fat-Based Nutrition. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Clinical Nutrition Market

The global clinical nutrition market is experiencing significant growth due to the increasing prevalence of lifestyle-related diseases and the rising elderly population. As individuals age, their activity levels diminish, metabolic rates decrease, and energy needs decline, leading to a deterioration in their ability to absorb and utilize essential nutrients. This decline amplifies their nutritional requirements, creating a heightened demand for clinical nutrition solutions that enhance energy absorption and utilization. Consequently, the growing emphasis on meeting the specific nutritional needs of older adults is poised to drive market expansion throughout the forecast period, reflecting a broader trend towards proactive health management.

Restraints in the Global Clinical Nutrition Market

The Global Clinical Nutrition market faces significant challenges, primarily due to a lack of awareness and the high costs associated with clinical nutrition products. Despite a rising demand for therapeutic nutritional solutions, both healthcare professionals and the general public remain largely uninformed about the benefits of clinical nutrition in both developed and developing nations. This limited understanding has contributed to widespread misinformation regarding vitamins and dietary practices, leading to nutritional deficiencies and related health issues. Consequently, the inadequate knowledge and appreciation of clinical nutrition serve as substantial barriers to market growth, hindering its expansion throughout the forecast period.

Market Trends of the Global Clinical Nutrition Market

The Global Clinical Nutrition market is witnessing significant growth fueled by enhanced healthcare infrastructure and a rising necessity for improved healthcare solutions, particularly in emerging regions like Asia-Pacific and LAMEA. This trend is further accelerated by the alarming rise in lifestyle-related chronic diseases that contribute to malnutrition and dietary complications. As healthcare demands evolve, there is an increased emphasis on research and development of specialized medical devices aimed at addressing diverse health issues, including respiratory, renal, and oncological conditions. Consequently, these factors are creating lucrative opportunities for expansion and innovation within the clinical nutrition sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Market Attractiveness Index
• Raw Material Analysis
• Pricing Analysis

Global Clinical Nutrition Market Size by Route of Administration & CAGR (2024-2031)

• Market Overview
• Oral
• Parenteral
• Enteral

Global Clinical Nutrition Market Size by Application & CAGR (2024-2031)

• Market Overview
• Cancer
• Neurological Diseases
• Gastrointestinal Disorder
• Metabolic Disorder
• Others

Global Clinical Nutrition Market Size by Distribution Channel & CAGR (2024-2031)

• Market Overview
• Online
• Offline
  • Retail Stores
  • Institutional Sales Channel
  • Others

Global Clinical Nutrition Market Size by End User & CAGR (2024-2031)

• Market Overview
• Pediatrics
• Adults
• Geriatric

Global Clinical Nutrition Market Size by Nutritional Content & CAGR (2024-2031)

• Market Overview
• Protein-Based Nutrition
• Vitamin and Mineral-Rich Nutrition
• Carbohydrate-Based Nutrition
• Fat-Based Nutrition

Global Clinical Nutrition Market Size & CAGR (2024-2031)

• North America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • US
  • Canada
• Europe, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nestle Health Science (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danone Nutricia (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mead Johnson Nutrition (Reckitt) (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK) (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ajinomoto Co., Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke DSM N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cambrooke Therapeutics (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Kelun Pharmaceutical Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hormel Health Labs (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Perrigo Company (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hero Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Victus (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Entrocare Nutritional Solutions (U.K.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation